Canadian Thoracic Society position statement on rehabilitation for COVID-19 and implications for pulmonary rehabilitation

Beauchamp, Marla K.; Janaudis-Ferreira, Tânia; Wald, Joshua; Aceron, Raymond; Bhutani, Mohit; Bourbeau, Jean; Brooks, Dina; Dechman, Gail; Goldstein, Roger; Goodridge, Donna; Hernández, Paul; Marciniuk, Darcy; Penz, Erika; Ryerson, Christopher J.; Saey, Didier; Stickland, Michael K.; Weatherald, Jason

doi:10.1080/24745332.2021.1992939

Cited by 9 publications

(11 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, there were no statistically significant differences between the variables of duration, follow‐up time, oxygen support, sample size, mean age, mean frequency and mean sample size. The principles of respiratory rehabilitation can be modified to meet the needs of post‐COVID‐19 patients who complain of cough, dyspnoea, decreased exercise tolerance and functional restrictions (Beauchamp et al, 2022). According to our analysis, comorbidities were found to be moderators of the pooled effect size in terms of patient characteristics.…”

Section: Discussionmentioning

confidence: 99%

“…These studies showed difference after respiratory rehabilitation when compared with studies that reported no comorbidities. Patients with comorbidities should still be given respiratory rehabilitation consideration; for example, those with heart disease and experiencing new or worsening symptoms after COVID‐19 should also have a cardiologist assessment to rule out myocarditis before starting rehabilitation (Beauchamp et al, 2022). In our result patients without comorbidities related to coronary heart disease and chronic lung disease had statistically significant higher effects for respiratory rehabilitation than patients who had these comorbidities.…”

Section: Discussionmentioning

confidence: 99%

“…Patients with comorbidities should still be given respiratory rehabilitation consideration; for example, those with heart disease and experiencing new or worsening symptoms after COVID-19 should also have a cardiologist assessment to rule out myocarditis before starting rehabilitation (Beauchamp et al, 2022). In our result patients without comorbidities related to coronary heart disease and chronic lung disease had statistically significant higher effects for respiratory rehabili- In addition, frequency, duration and the kind of exercise program are statistically essential variables related to intervention characteristics and must be considered.…”

Section: Moderator Variables Of Respiratory Rehabilitationmentioning

confidence: 99%

See 2 more Smart Citations

Effectiveness of respiratory rehabilitation in patients with COVID‐19: A meta‐analysis

Ashra

Jen

Liu

et al. 2023

Journal of Clinical Nursing

View full text Add to dashboard Cite

Aim: Examine effectiveness of respiratory rehabilitation and moderating factors on lung function and exercise capacity in post-COVID-19 patients. Design: Meta-analysis. Methods: R software 4.0.2 assessed the effectiveness of respiratory rehabilitation adopting the random-effects model and presenting standardised mean differences (SMDs). Heterogeneity was determined by Cochran's Q and I 2 . The Cochrane Risk of Bias 2.0 and MINORS evaluated quality of the included studies.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Moderator Variables Of Respiratory Rehabilitationmentioning

confidence: 99%

See 1 more Smart Citation

Effectiveness of respiratory rehabilitation in patients with COVID‐19: A meta‐analysis

Ashra

Jen

Liu

et al. 2023

Journal of Clinical Nursing

View full text Add to dashboard Cite

show abstract

“…We also found that over a third of individuals with COVID-19 who reported moderate/ severe shortness of breath, decreased sense of smell, trouble with balance, and wet cough indicated that these symptoms persisted for >3 months, consistent with NICE guidance on long COVID (symptoms lasting >12 weeks) 30 . Importantly, many of these symptoms can be improved with rehabilitation and these data suggest there may be unmet needs for rehabilitative care among community-dwelling patients with COVID-19 who did not require hospital treatment 31,32 . Finally, we found the rate of persistent symptoms was higher in females, those with pre-pandemic multimorbidity and lower levels of subjective social status but did not differ significantly by age.…”

Section: Discussionmentioning

confidence: 99%

Persistent COVID-19 symptoms in community-living older adults from the Canadian Longitudinal Study on Aging (CLSA)

et al. 2023

View full text Add to dashboard Cite

Background Symptom persistence in non-hospitalized COVID-19 patients, also known as Long COVID or Post-acute Sequelae of COVID-19, is not well characterized or understood, and few studies have included non-COVID-19 control groups. Methods We used data from a cross-sectional COVID-19 questionnaire (September-December 2020) linked to baseline (2011–2015) and follow-up (2015–2018) data from a population-based cohort including 23,757 adults 50+ years to examine how age, sex, and pre-pandemic physical, psychological, social, and functional health were related to the severity and persistence of 23 COVID-19-related symptoms experienced between March 2020 and questionnaire completion. Results The most common symptoms are fatigue, dry cough, muscle/joint pain, sore throat, headache, and runny nose; reported by over 25% of participant who had (n = 121) or did not have (n = 23,636) COVID-19 during the study period. The cumulative incidence of moderate/severe symptoms in people with COVID-19 is more than double that reported by people without COVID-19, with the absolute difference ranging from 16.8% (runny nose) to 37.8% (fatigue). Approximately 60% of male and 73% of female participants with COVID-19 report at least one symptom persisting >1 month. Persistence >1 month is higher in females (aIRR = 1.68; 95% CI: 1.03, 2.73) and those with multimorbidity (aIRR = 1.90; 95% CI: 1.02, 3.49); persistence >3 months decreases by 15% with each unit increase in subjective social status after adjusting for age, sex and multimorbidity. Conclusions Many people living in the community who were not hospitalized for COVID-19 still experience symptoms 1- and 3-months post infection. These data suggest that additional supports, for example access to rehabilitative care, are needed to help some individuals fully recover.

show abstract

“…Guidelines on rehabilitation of post-COVID-19 patients have been published by various professional societies. 131 132 133 Low to moderate intensity physical exercise at home in the 6 to 8 weeks after discharge is recommended by the joint American Thoracic Society/European Respiratory Society guidelines for COVID-19 survivors. 133 The American Academy of Physical Medicine and Rehabilitation has published recommendations that begin with a baseline assessment of symptoms, mood disorders, and other comorbidities.…”

Section: Supportive Carementioning

confidence: 99%

“Long Haulers”

Lutchmansingh

Sevilla

Possick

et al. 2023

Semin Respir Crit Care Med

View full text Add to dashboard Cite

Post-COVID conditions continue to afflict patients long after acute severe acute respiratory syndrome-coronavirus-2 (SARS CoV-2) infection. Over 50 symptoms across multiple organ systems have been reported, with pulmonary, cardiovascular, and neuropsychiatric sequelae occurring most frequently. Multiple terms have been used to describe post-COVID conditions including long COVID, long-haul COVID, postacute coronavirus disease 2019 (COVID-19), postacute sequelae of SARS-CoV-2 infection, long-term effects of COVID, and chronic COVID-19; however, standardized assessments and treatment algorithms for patients have generally been lacking. This review discusses the epidemiology and risk factors for post-COVID conditions and provides a general overview of the diagnostic assessment and treatment of specific manifestations. Data derived from the multitude of observational studies and scientific investigations into pathogenesis are providing a clearer understanding of the distinct phenotypes of post-COVID conditions. Insight gained from these studies and ongoing interventional trials continues to lead to the development of clinical protocols directed toward improving COVID-19 survivors' quality of life and preventing or reducing long-term morbidity.

show abstract

Canadian Thoracic Society position statement on rehabilitation for COVID-19 and implications for pulmonary rehabilitation

Cited by 9 publications

References 16 publications

Effectiveness of respiratory rehabilitation in patients with COVID‐19: A meta‐analysis

Effectiveness of respiratory rehabilitation in patients with COVID‐19: A meta‐analysis

Persistent COVID-19 symptoms in community-living older adults from the Canadian Longitudinal Study on Aging (CLSA)

“Long Haulers”

Contact Info

Product

Resources

About